We are live on ! Find out more
FG

Formula Growth Portfolio holdings

AUM $284M Turnover 33.14%
1-Year Est. Return 54.56%
This Fund
S&P 500
This Quarter Est. Return
+39.63%
1 Year Est. Return
+54.56%
3 Year Est. Return
+117.67%
5 Year Est. Return
+78.26%
10 Year Est. Return
+276.27%
AUM
$284M
AUM Growth
+$62.7M
Cap. Flow
+$6.37M
Cap. Flow %
2.24%
Top 10 Hldgs %
22.84%
Holding
169
New
32
Increased
28
Reduced
43
Closed
24
Avg Time Held
2.8 years
Top 10 Avg Time Held
0.7 years
Top 20 Avg Time Held
0.5 years

Top Buys

Rank Stock Value
1
CALX icon
Calix
CALX
+$3.23M
2
KVYO icon
Klaviyo
KVYO
+$2.49M
3
GH icon
Guardant Health
GH
+$2.1M
4
EQPT icon
EquipmentShare.com Inc
EQPT
+$1.66M
5
AVEX icon
AEVEX Corp
AVEX
+$1.53M

Top Sells

Rank Stock Value
1
MU icon
Micron Technology
MU
+$6.75M
2
NOK icon
Nokia
NOK
+$3.54M
3
FPS icon
Forgent Power Solutions
FPS
+$2.4M
4
NAVN icon
Navan Inc
NAVN
+$1.85M
5
ARCB icon
ArcBest
ARCB
+$1.85M

Sector Composition

Rank Sector Weight
1 Technology 31.94%
2 Industrials 25.15%
3 Healthcare 16.98%
4 Consumer Discretionary 12.68%
5 Financials 4.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
SAH icon
26
Sonic Automotive
SAH
$2.01B
$3.04M 1.07%
35,800
– –
2015 Q4
42 quarters
LAW icon
27
CS Disco
LAW
$288M
$3.02M 1.06%
800,000
– –
2023 Q1
13 quarters
FN icon
28
Fabrinet
FN
$13B
$3.02M 1.06%
5,370
-1,030
-16% -$664K
2017 Q2
36 quarters
AIR icon
29
AAR Corp
AIR
$3.97B
$2.99M 1.05%
20,890
-84
-0.4% -$9.9K
2025 Q4
2 quarters
AX icon
30
Axos Financial
AX
$5B
$2.98M 1.05%
30,624
– –
2015 Q4
42 quarters
GH icon
31
Guardant Health
GH
$21.3B
$2.9M 1.02%
+19,300
New +$2.1M
2026 Q2
0 quarters
UTHR icon
32
United Therapeutics
UTHR
$22.9B
$2.89M 1.02%
5,334
-22
-0.4% -$12.4K
2025 Q1
5 quarters
LULU icon
33
lululemon athletica
LULU
$11.2B
$2.85M 1%
25,000
+5,000
+25% +$668K
2025 Q4
2 quarters
MEC icon
34
Mayville Engineering Co
MEC
$354M
$2.81M 0.99%
75,000
-25,000
-25% -$668K
2025 Q4
2 quarters
LNTH icon
35
Lantheus
LNTH
$6.51B
$2.79M 0.98%
25,131
+9,131
+57% +$851K
2026 Q1
1 quarter
BILL icon
36
BILL Holdings
BILL
$3.89B
$2.71M 0.95%
75,000
– –
2023 Q4
10 quarters
NOK icon
37
Nokia
NOK
$51.2B
$2.66M 0.93%
200,000
-275,000
-58% -$3.54M
2025 Q4
2 quarters
EVH icon
38
Evolent Health
EVH
$517M
$2.63M 0.92%
485,000
+270,000
+126% +$1.04M
2026 Q1
1 quarter
CPA icon
39
Copa Holdings
CPA
$5.43B
$2.41M 0.85%
15,500
– –
2015 Q4
42 quarters
NSP icon
40
Insperity
NSP
$1.96B
$2.34M 0.82%
56,700
-10,000
-15% -$328K
2025 Q4
2 quarters
RH icon
41
RH
RH
$2.14B
$2.31M 0.81%
14,000
+1,000
+8% +$138K
2025 Q1
5 quarters
AGYS icon
42
Agilysys
AGYS
$3.1B
$2.3M 0.81%
22,000
+10,000
+83% +$774K
2026 Q1
1 quarter
CDNA icon
43
CareDx
CDNA
$3.31B
$2.22M 0.78%
78,026
-452
-0.6% -$9.8K
2024 Q4
6 quarters
FCFS icon
44
FirstCash
FCFS
$9.34B
$2.16M 0.76%
10,000
– –
2015 Q4
42 quarters
SSNC icon
45
SS&C Technologies
SSNC
$19.7B
$2.15M 0.76%
34,725
– –
2015 Q4
42 quarters
TPC icon
46
Tutor Perini Cor
TPC
$4.08B
$2.04M 0.72%
24,586
-4,376
-15% -$352K
2024 Q3
7 quarters
JBHT icon
47
JB Hunt Transport Services
JBHT
$21.5B
$2.03M 0.71%
7,000
– –
2017 Q4
34 quarters
MDB icon
48
MongoDB
MDB
$27.2B
$2.02M 0.71%
6,000
-3,000
-33% -$900K
2026 Q1
1 quarter
HCA icon
49
HCA Healthcare
HCA
$99.3B
$1.95M 0.69%
5,000
– –
2015 Q4
42 quarters
GPN icon
50
Global Payments
GPN
$22.1B
$1.94M 0.68%
26,759
+14,000
+110% +$964K
2025 Q1
5 quarters

Similar funds

Formula Growth's Q2 2026 Portfolio in Review

As of Q2 2026, Formula Growth held 169 positions worth $284M, up 28% from $222M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Formula Growth's Q2 2026 filing shows 32 new, 28 increased, 43 reduced and 24 closed positions. Its largest new stake was Guardant Health: 19,300 shares worth $2.9M. The largest sale was Micron Technology, an estimated $6.75M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Industrials and Healthcare.

  • Formula Growth's largest Q2 2026 buy was Guardant Health: 19,300 shares worth $2.9M.
  • Formula Growth added most to Calix in Q2 2026, an estimated $3.23M increase.
  • Formula Growth's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $6.75M.
  • Formula Growth fully exited Navan Inc in Q2 2026, selling an estimated $1.85M.
  • Formula Growth's ten largest holdings make up 23% of its $284M portfolio in Q2 2026.
  • Formula Growth opened 32 new positions and closed 24 in Q2 2026.
  • Formula Growth's portfolio value rose 28% quarter-over-quarter to $284M.

Based on Formula Growth's 13F filing for Q2 2026, filed 17 Aug 2026.